PRAVEEN TYLE Insider Trading Transactions
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for PRAVEEN TYLE.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of PRAVEEN TYLE. PRAVEEN TYLE is Senior Vice President in BAUSCH & LOMB INC ($BOL) and EVP, R&D in LEXICON PHARMACEUTICALS, INC. ($LEXG) and Director in EYEGATE PHARMACEUTICALS INC ($EYEG).
Latest Insider Trading Transactions of PRAVEEN TYLE
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, BOL, EYEG, LEXG
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Mar 02 2021 | LEXG | LEXICON PHARMACEUT ... | TYLE PRAVEEN | EVP, R&D | Option Exercise | M | 0.00 | 28,690 | 0 | 57,380 | |
| Mar 02 2021 | LEXG | LEXICON PHARMACEUT ... | TYLE PRAVEEN | EVP, R&D | Option Exercise | M | 0.00 | 26,600 | 0 | 26,600 | |
| Mar 02 2021 | LEXG | LEXICON PHARMACEUT ... | TYLE PRAVEEN | EVP, R&D | Option Exercise | M | 0.00 | 9,727 | 0 | 0 | |
| Mar 02 2021 | LEXG | LEXICON PHARMACEUT ... | TYLE PRAVEEN | EVP, R&D | Option Exercise | M | 0.00 | 2,990 | 0 | 0 | |
| Mar 02 2021 | LEXG | LEXICON PHARMACEUT ... | TYLE PRAVEEN | EVP, R&D | Payment of Exercise | F | 7.19 | 16,560 | 119,066 | 120,791 | 137.4 K to 120.8 K (-12.06 %) |
| Mar 02 2021 | LEXG | LEXICON PHARMACEUT ... | TYLE PRAVEEN | EVP, R&D | Buy | M | 0.00 | 28,690 | 0 | 137,351 | 108.7 K to 137.4 K (+26.40 %) |
| Mar 02 2021 | LEXG | LEXICON PHARMACEUT ... | TYLE PRAVEEN | EVP, R&D | Buy | M | 0.00 | 26,600 | 0 | 108,661 | 82.1 K to 108.7 K (+32.41 %) |
| Mar 02 2021 | LEXG | LEXICON PHARMACEUT ... | TYLE PRAVEEN | EVP, R&D | Buy | M | 0.00 | 9,727 | 0 | 82,061 | 72.3 K to 82.1 K (+13.45 %) |
| Mar 02 2021 | LEXG | LEXICON PHARMACEUT ... | TYLE PRAVEEN | EVP, R&D | Buy | M | 0.00 | 2,990 | 0 | 72,334 | 69.3 K to 72.3 K (+4.31 %) |
| Feb 03 2021 | EYEG | EYEGATE PHARMACEUT ... | TYLE PRAVEEN | Director | Option Exercise | A | 6.46 | 3,333 | 21,531 | 3,333 | |
| Apr 24 2020 | LEXG | LEXICON PHARMACEUT ... | TYLE PRAVEEN | EVP, R&D | Payment of Exercise | F | 1.96 | 4,844 | 9,494 | 69,344 | 74.2 K to 69.3 K (-6.53 %) |
| Apr 24 2020 | LEXG | LEXICON PHARMACEUT ... | TYLE PRAVEEN | EVP, R&D | Grant | A | 0.00 | 19,893 | 0 | 74,188 | 54.3 K to 74.2 K (+36.64 %) |
| Mar 03 2020 | LEXG | LEXICON PHARMACEUT ... | TYLE PRAVEEN | EVP, R&D | Option Exercise | M | 0.00 | 26,600 | 0 | 53,200 | |
| Mar 03 2020 | LEXG | LEXICON PHARMACEUT ... | TYLE PRAVEEN | EVP, R&D | Option Exercise | M | 0.00 | 9,726 | 0 | 9,727 | |
| Mar 03 2020 | LEXG | LEXICON PHARMACEUT ... | TYLE PRAVEEN | EVP, R&D | Option Exercise | M | 0.00 | 2,990 | 0 | 2,990 | |
| Mar 03 2020 | LEXG | LEXICON PHARMACEUT ... | TYLE PRAVEEN | EVP, R&D | Buy | M | 0.00 | 26,600 | 0 | 54,295 | 27.7 K to 54.3 K (+96.05 %) |
| Mar 03 2020 | LEXG | LEXICON PHARMACEUT ... | TYLE PRAVEEN | EVP, R&D | Buy | M | 0.00 | 9,726 | 0 | 27,695 | 18 K to 27.7 K (+54.13 %) |
| Mar 03 2020 | LEXG | LEXICON PHARMACEUT ... | TYLE PRAVEEN | EVP, R&D | Buy | M | 0.00 | 2,990 | 0 | 17,969 | 15 K to 18 K (+19.96 %) |
| Feb 19 2020 | EYEG | EYEGATE PHARMACEUT ... | TYLE PRAVEEN | Director | Option Exercise | A | 6.55 | 3,333 | 21,831 | 3,333 | |
| Mar 01 2019 | LEXG | LEXICON PHARMACEUT ... | TYLE PRAVEEN | EVP, R&D | Option Exercise | M | 0.00 | 9,727 | 0 | 19,453 | |
| Mar 01 2019 | LEXG | LEXICON PHARMACEUT ... | TYLE PRAVEEN | EVP, R&D | Option Exercise | M | 0.00 | 2,990 | 0 | 5,980 | |
| Mar 01 2019 | LEXG | LEXICON PHARMACEUT ... | TYLE PRAVEEN | EVP, R&D | Buy | M | 0.00 | 9,727 | 0 | 14,979 | 5.3 K to 15 K (+185.21 %) |
| Mar 01 2019 | LEXG | LEXICON PHARMACEUT ... | TYLE PRAVEEN | EVP, R&D | Buy | M | 0.00 | 2,990 | 0 | 5,252 | 2.3 K to 5.3 K (+132.18 %) |
| Feb 08 2019 | LEXG | LEXICON PHARMACEUT ... | TYLE PRAVEEN | EVP, R&D | Option Exercise | A | 0.00 | 79,800 | 0 | 79,800 | |
| Feb 08 2019 | LEXG | LEXICON PHARMACEUT ... | TYLE PRAVEEN | EVP, R&D | Option Exercise | A | 5.16 | 148,200 | 764,712 | 148,200 | |
| Feb 05 2019 | EYEG | EYEGATE PHARMACEUT ... | TYLE PRAVEEN | Director | Option Exercise | A | 0.48 | 50,000 | 24,000 | 50,000 | |
| Jul 12 2018 | EYEG | EYEGATE PHARMACEUT ... | TYLE PRAVEEN | Director | Grant | A | 0.00 | 50,000 | 0 | 61,893 | 11.9 K to 61.9 K (+420.42 %) |
| Mar 02 2018 | LEXG | LEXICON PHARMACEUT ... | TYLE PRAVEEN | EVP, R&D | Option Exercise | M | 0.00 | 2,990 | 0 | 8,970 | |
| Mar 02 2018 | LEXG | LEXICON PHARMACEUT ... | TYLE PRAVEEN | EVP, R&D | Payment of Exercise | F | 8.53 | 728 | 6,210 | 2,262 | 3 K to 2.3 K (-24.35 %) |
| Mar 02 2018 | LEXG | LEXICON PHARMACEUT ... | TYLE PRAVEEN | EVP, R&D | Buy | M | 0.00 | 2,990 | 0 | 2,990 | 0 to 3 K |
| Feb 12 2018 | LEXG | LEXICON PHARMACEUT ... | TYLE PRAVEEN | EVP, R&D | Option Exercise | A | 9.79 | 82,820 | 810,808 | 82,820 | |
| Feb 12 2018 | LEXG | LEXICON PHARMACEUT ... | TYLE PRAVEEN | EVP, R&D | Option Exercise | A | 0.00 | 29,180 | 0 | 29,180 | |
| Jun 22 2017 | EYEG | EYEGATE PHARMACEUT ... | TYLE PRAVEEN | Director | Option Exercise | A | 1.35 | 15,000 | 20,250 | 15,000 | |
| Feb 13 2017 | LEXG | LEXICON PHARMACEUT ... | TYLE PRAVEEN | EVP, R&D | Option Exercise | A | 0.00 | 11,960 | 0 | 11,960 | |
| Feb 13 2017 | LEXG | LEXICON PHARMACEUT ... | TYLE PRAVEEN | EVP, R&D | Option Exercise | A | 14.44 | 47,860 | 691,098 | 47,860 | |
| May 16 2016 | LEXG | LEXICON PHARMACEUT ... | TYLE PRAVEEN | EVP, R&D | Option Exercise | A | 12.24 | 100,000 | 1,224,000 | 100,000 | |
| Mar 31 2016 | EYEG | EYEGATE PHARMACEUT ... | TYLE PRAVEEN | Director | Option Exercise | A | 3.06 | 7,282 | 22,283 | 7,282 | |
| Jan 27 2016 | EYEG | EYEGATE PHARMACEUT ... | TYLE PRAVEEN | Director | Option Exercise | A | 1.70 | 3,000 | 5,100 | 3,000 | |
| Sep 01 2015 | EYEG | EYEGATE PHARMACEUT ... | TYLE PRAVEEN | Director | Option Exercise | A | 3.59 | 8,000 | 28,720 | 8,000 | |
| Sep 01 2015 | EYEG | EYEGATE PHARMACEUT ... | TYLE PRAVEEN | Director | Grant | A | 0.00 | 5,748 | 0 | 11,893 | 6.1 K to 11.9 K (+93.54 %) |
| May 05 2015 | EYEG | EYEGATE PHARMACEUT ... | TYLE PRAVEEN | Director | Grant | A | 0.00 | 11,893 | 0 | 11,893 | 0 to 11.9 K |
| Feb 26 2015 | EYEG | EYEGATE PHARMACEUT ... | TYLE PRAVEEN | Director | Option Exercise | A | 5.75 | 20,000 | 115,000 | 20,000 | |
| Feb 23 2015 | EYEG | EYEGATE PHARMACEUT ... | TYLE PRAVEEN | Director | Option Exercise | A | 6.00 | 2,276 | 13,656 | 36,051 | |
| Oct 30 2007 | BOL | BAUSCH & LOMB ... | TYLE PRAVEEN | Senior Vice Preside ... | Option Exercise | M | 0.00 | 14,991 | 0 | 0 | |
| Oct 30 2007 | BOL | BAUSCH & LOMB ... | TYLE PRAVEEN | Senior Vice Preside ... | Option Exercise | M | 0.00 | 1,248 | 0 | 0 | |
| Oct 30 2007 | BOL | BAUSCH & LOMB ... | TYLE PRAVEEN | Senior Vice Preside ... | Option Exercise | M | 0.00 | 1,786 | 0 | 0 | |
| Oct 30 2007 | BOL | BAUSCH & LOMB ... | TYLE PRAVEEN | Senior Vice Preside ... | Option Exercise | D | 61.31 | 35,000 | 2,145,675 | 0 | |
| Oct 30 2007 | BOL | BAUSCH & LOMB ... | TYLE PRAVEEN | Senior Vice Preside ... | Buy | M | 0.00 | 18,025 | 0 | 0 | -18,025 to 0 (-100.00 %) |
| Oct 30 2007 | BOL | BAUSCH & LOMB ... | TYLE PRAVEEN | Senior Vice Preside ... | Sell | D | 0.00 | 452 | 0 | 0 | 452 to 0 (-100.00 %) |
| Oct 30 2007 | BOL | BAUSCH & LOMB ... | TYLE PRAVEEN | Senior Vice Preside ... | Sell | D | 0.00 | 45,324 | 0 | 0 | 45.3 K to 0 (-100.00 %) |
Page: 1